TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 10/10/2008
More...
|
Abiomed (ABMD) Receives 510(k) Clearance from FDA for Impella 2.5 Device 6/2/2008
More...
|
Abbott Vascular (ABT) Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 6/2/2008
More...
|
Abbott Vascular Devices (ABT) Gains Reimbursement for XIENCE(TM) V Drug Eluting Stent in France 2/1/2008
More...
|
Bypass Better Than Stents For Coronary Disease 1/24/2008
More...
|
The Medicines Company (MDCO) Angiox(R) Alone Reduced Early Bleeding and Resulted in Similar One-Year Mortality 9/4/2007
More...
|
BusinessWeek Article Highlights Cardiovascular BioTherapeutics, Inc. (CVBT.OB) for Developing a Promising Protein Therapy to Treat Coronary Artery Disease 7/6/2007
More...
|
Northwestern University Study Finds Drug-Coated Stents Safe for Coronary Artery Blockages 5/29/2007
More...
|
Irregular Heartbeat Linked to Genetic Mutation, Mayo Clinic (Jobs) Study Shows 2/26/2007
More...
|
Angioplasty Becoming Safer For Octogenarians 12/19/2006
More...
|
Alchemia Release: Arixtra(R) Receives Priority Review By The FDA In Acute Coronary Syndromes (ACS) 10/4/2006
More...
|
Bypass Surgery Tops Angioplasty For Sickest Heart Patients 10/2/2006
More...
|
GlaxoSmithKline (GSK) Release: FDA Grants Priority Review For ARIXTRA(R) (fondaparinux sodium) In The Treatment Of Acute Coronary Syndromes 10/2/2006
More...
|
Lumen Biomedical, Inc. Announces The Successful Initiation Of Its FiberNet(R) Carotid Embolic Protection US IDE Trial 7/18/2006
More...
|
Cytori Therapeutics, Inc. (CYTX) Reports Safety And Efficacy Of Its Celution System(TM) In A Preclinical Study Of Coronary Artery Disease 7/17/2006
More...
|
Ranbaxy Pharmaceuticals Inc. Receives FDA Approval To Market Simvastatin 80mg Tablets With 180-Day Exclusivity 6/26/2006
More...
|
diaDexus Release: New Data Published In An American Heart Association Journal Shows That Lipoprotein-Associated Phospholipase A2 Independently Adds To The Diagnostic Accuracy Of Traditional Risk Assessment For Future Cardiovascular Events 6/26/2006
More...
|
Johnson & Johnson (JNJ)'s Cordis Corporation (JNJ) Unit Gets European OK For New Cypher Stent 6/22/2006
More...
|
X-Cell Medical, Inc. Completes Enrollment For Clinical Trial Of ETHOS II Estradiol Eluting Stent 5/16/2006
More...
|
Medtronic, Inc. (MDT) Receives FDA Approval For Micro-Driver Stent 5/1/2006
More...
|
Neuren Pharmaceuticals Limited Announces Successful Phase 2 Results For Its Lead Candidate Glypromate(R) 4/13/2006
More...
|
FDA Issues Public Health Advisory For Bayer AG (BAY)'s Trasylol; Drug Linked To Higher Risks Of Serious Side Effects 2/8/2006
More...
|
Alexion Pharmaceuticals Inc. (ALXN) Reports Phase III Results for PRIMO-CABG2 Study; Drug Trial Fails To Meet Expectations 11/23/2005
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Receives Favorable Court Ruling On Generic Pravachol(R) Exclusivity 10/21/2005
More...
|
Medtronic, Inc. (MDT) Stent Misses Target 10/17/2005
More...
|
Johnson & Johnson (JNJ) Advised By Canadian Competition Bureau On Proposed Acquisition Of Guidant Corporation (GDT) 9/2/2005
More...
|
Vascular Solutions (VASC) Gets FDA Device OK 8/17/2005
More...
|
Terumo Corporation Completes Twentieth Case Of DuraHeart Artificial Heart Implantation 7/26/2005
More...
|
Singapore-Listed Biosensors International Obtains CE Mark Approval For Axxion Drug-Eluting Stent 7/12/2005
More...
|
Alexion Pharmaceuticals Inc. (ALXN) Reports Results Of Eculizumab Extension Trial In PNH In The Journal Blood 6/29/2005
More...
|
Scott And Scott, LLC Files Initial Securities Fraud Class Action Lawsuit Against Guidant Corporation (GDT) 6/27/2005
More...
|
Jury Finds Cordis Corporation (JNJ) Patents Infringed By Boston Scientific Corporation (BSX) Stents 6/21/2005
More...
|
Boston Scientific Corporation (BSX) Release: Next-Generation TAXUS(R) Liberte(TM) Coronary Stent System Registry Completes First Enrollment Phase 6/20/2005
More...
|
Terumo Europe N.V. Enrolls First Patient In Clinical Trial Of Nobori(TM) Drug-Eluting Coronary Stent 5/27/2005
More...
|
Biosensors International Releases Favourable Preliminary 12-Month Results From Drug-Eluting Stent Trial 5/27/2005
More...
|
Sorin Group Announces Excellent 6-Month Interim Clinical Results Of JANUS Drug-Eluting Stent JUPITER II Trial 5/27/2005
More...
|
EndoTex Interventional Systems, Inc.'s Carotid Artery Stenting Trial (CABERNET) Demonstrates Favorable Outcomes In High-Risk Patients 5/26/2005
More...
|
Boston Scientific Corporation (BSX) Announces 400th Patient Enrolled In Study Of Next-Generation TAXUS(R) Liberte(TM) Coronary Stent System 5/26/2005
More...
|
Cordis Corporation (JNJ) Four-Year Clinical Results From The RAVEL Trial Show Sustained Clinical Benefits With The CYPHER(R) Sirolimus-Eluting Coronary Stent 5/25/2005
More...
|
Conor Medsystems, Inc. Initiates COSTAR II Pivotal Drug-Eluting Stent Clinical Trial In U.S. 5/24/2005
More...
|
FDA Approves 12-Month Shelf Life For TAXUS(R) Stent System 5/23/2005
More...
|
Myogen (MYOG) Initiates Trial Of Ambrisentan In Patients Who Previously Failed Other ERA Therapy 5/20/2005
More...
|
Cardiovascular Systems, Inc. Announces CE Mark For Its Orbital Atherectomy System For The Treatment Of Peripheral Artery Disease 5/19/2005
More...
|
Abbott Laboratories (ABT) Enrolls First Patient In Pivotal Drug-Eluting Stent Clinical Trial 5/17/2005
More...
|
Nabi Biopharmaceuticals (NABI) Initiates StaphVAX(R) Immunogenicity Study In Orthopedic Surgery Patients In The United Kingdom 5/17/2005
More...
|
IMI International Medical Innovations Inc. (IMI) Release: PREVU(x) Study To Open New Markets 5/10/2005
More...
|
Conor Medsystems, Inc. Receives CE Mark Approval For UniStar(TM) Cobalt Chromium Stent 5/10/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Announces Positive Safety Data 5/4/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Partner Announces First International Trial Of A Paclitaxel-Eluting Stent For Peripheral Artery Disease 5/3/2005
More...
|
CABG Medical Inc. Announces Initiation Of CE Mark Clinical Trial 5/3/2005
More...
|
MIDAS Research Initiates Research Coverage On Estracure Inc. 4/29/2005
More...
|
Boston Scientific Corporation (BSX) Announces Excellent Results In Study Of Patients With Carotid Artery Disease 4/27/2005
More...
|
Cordis Corporation (JNJ) Release: CYPHER(R) Sirolimus-Eluting Coronary Stent Receives FDA Approval For MRI Scans Immediately Following Implantation 4/20/2005
More...
|
Medicure Inc. (MCU) Announces Successful DSMB Review From Ongoing Phase II/III MEND-CABG Trial 4/19/2005
More...
|
CV Therapeutics, Inc. (CVTX) Release: Ranexa(TM) (ranolazine) Meets Primary Endpoint In Approval-Enabling ERICA Study; Stocks Surge 4/18/2005
More...
|
Boston Scientific Corporation (BSX) Announces Acquisition Of TriVascular, Inc. 4/18/2005
More...
|
Kensey Nash Corporation (KNSY) Reports Results From Large European Study For Its TriActiv(R) System 4/18/2005
More...
|
Boston Scientific Corporation (BSX) Announces FDA Approval And Launch Of Liberte(TM) Coronary Stent System 4/14/2005
More...
|
Impulse Dynamics Launches Phase II Heart Failure Investigational Study In The U.S. Evaluating Use Of New Implantable Pulse Generator 4/13/2005
More...
|
Boston Scientific Corporation (BSX) Begins Exclusive International Distribution Of NexStent(TM) Carotid Stent 4/13/2005
More...
|
MIV Therapeutics Inc. (MIVT) Chief Medical Officer Discusses Recently Filed Patents In Online Interview 4/13/2005
More...
|
EndoTex Interventional Systems, Inc. Announces European Approval Of Novel Carotid Stent Delivery System 4/13/2005
More...
|
Boston Scientific Corporation (BSX) Announces Start Of Enrollment In Groundbreaking Clinical Trial Comparing Drug-Eluting Stents To Cardiac Surgery 4/12/2005
More...
|
Novadaq Technologies, Inc. Reports Positive Results In CABG Study 4/12/2005
More...
|
CardioTech International, Inc. (CTE) To Report On CardioPass Graft To Brazilian Surgeons 4/12/2005
More...
|
CardioTech International, Inc. (CTE) Announces Submission Of CE Marking Application For CardioPass Artificial Coronary Artery Bypass Graft 4/8/2005
More...
|
MedicalCV Announces Sales Of The Omnicarbon(R) Mechanical Heart Valve To Cease On April 30, 2005 4/8/2005
More...
|
Biopure Corporation (BPUR) Completes Patient Enrollment In European Phase 2 Clinical Trial Of Hemopure(R) In Coronary Angioplasty Patients 4/6/2005
More...
|
American BioScience, Inc. Presents Clinical Trial Results Of The First Human Study Of Coroxane(TM) For The Treatment Of Restenosis At The Cardiovascular Revascularization Therapies (CRT) Conference 4/5/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Partner First To Receive FDA Approval Allowing Immediate MRI Exams For Its TAXUS(R) Express(2)(TM) Paclitaxel-Eluting Stent System 4/5/2005
More...
|
CardioTech International, Inc. (CTE) Announces Successful Launch Of Interventional Cardiology Start-Up 4/4/2005
More...
|
IsoTis OrthoBiologics Receives FDA 510(k) Clearance For DynaGraft II 4/4/2005
More...
|
Corgentech, Inc. (CGTK) And Bristol-Myers Squibb Company (BMY) Announce Results From Edifoligide (E2F Decoy) Phase 3 Trial For Coronary Artery Bypass Graft Failure; Failed To Meet The Trial's Primary And Secondary Endpoints 3/30/2005
More...
|
Kensey Nash Corporation (KNSY) Announces Commencement Of ASPIRE Study For New TriActiv(R) FX(TM) Embolic Protection System 3/30/2005
More...
|
Completed Alltracel Pharmaceuticals Plc Pre-Clinical Studies Indicate Significant Longer Term Coronary Health Benefits Of The m.doc(TM) Technology Platform And An Additive Method Of Action To Both Sterols And Statins 3/23/2005
More...
|
Angiotech Pharmaceuticals (ANPI) And CABG Medical Inc. Enter Exclusive License Agreement To Extend Paclitaxel Technology Into Coronary Bypass Surgery 3/23/2005
More...
|
Angiotech Pharmaceuticals (ANPI) First U.S. Drug-Eluting Stent Trial To Treat Peripheral Arterial Disease Enrolls First Patient At Stanford University Medical Center 3/23/2005
More...
|
Conor Medsystems, Inc. Receives Conditional IDE Approval From The FDA To Begin COSTAR II Pivotal Clinical Trial 3/23/2005
More...
|
Lumen Therapeutics Begins Phase I/IIA Trial Of LT-1951 For Prevention Of Coronary Artery Bypass Graft (CABG) Failure 3/22/2005
More...
|
ev3 Inc. Announces Enrollment Has Begun For SpideRX(TM) Embolic Protection Device In Second Phase Of Carotid Clinical Trial 3/22/2005
More...
|
Thoratec Corporation (THOR) Announces Initiation Of Enrollment In HeartMate(R) II Pivotal Trial 3/17/2005
More...
|
Shareholder Class Action Filed Against Cell Therapeutics, Inc. (CTIC) By The Law Firm Of Schiffrin & Barroway, LLP 3/11/2005
More...
|
Bristol-Myers Squibb Company (BMY) And Sanofi-Aventis (France) (SASY.PA) Release: Results From Two Major Clinical Trials Presented At American College Of Cardiology 3/9/2005
More...
|
CV Therapeutics, Inc. (CVTX) Release: Data From ASCOT Study Which Included Perindopril Presented As Late Breaker At American College Of Cardiology Scientific Sessions 2005 3/9/2005
More...
|
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) Release: Data Support The Positive Clinical Benefits Of GP IIb-IIIa Inhibitors And INTEGRILIN(R) (eptifibatide) Injection 3/9/2005
More...
|
Guilford Pharmaceuticals Inc. (GLFD) Release: AGGRASTAT(R) Injection Clinical Data Presented At American College Of Cardiology Annual Meeting 3/8/2005
More...
|
Allon Therapeutics, Inc. Compounds Show Potential To Treat Eye Disease 3/8/2005
More...
|
Conor Medsystems, Inc. Presents Positive 12-Month Results From PISCES First Generation Paclitaxel Drug-Eluting Stent Trial At American College Of Cardiology Scientific Session 3/8/2005
More...
|
Alexion Pharmaceuticals (ALXN) Appoints Dr. Ruedi E. Waeger To Board Of Directors 3/8/2005
More...
|
diaDexus Presents Abstracts At Scientific Sessions 3/8/2005
More...
|
Boston Scientific Corporation (BSX) Announces Completion Of Acquisition Of Advanced Stent Technologies, Inc. 3/7/2005
More...
|
IMI International Medical Innovations (IMI) Release: Growing Evidence That Skin Sterol Is Linked To Hidden Heart Disease 3/7/2005
More...
|
Kensey Nash Corporation (KNSY) Announces CE Mark Approval For New TriActiv(R) FX(TM) Embolic Protection System 3/7/2005
More...
|
Cordis Corporation (JNJ) Release: Arts II Clinical Study Shows Promising Results For The Cypher(R) Sirolimus-Eluting Coronary Stent In Patients With Multi-Vessel Disease 3/7/2005
More...
|
Vascular Solutions (VASC) Announces Japanese Approval Of Pronto Extraction Catheter 3/7/2005
More...
|
Conor Medsystems, Inc. Announces Positive Angiographic And Clinical Results For EuroSTAR Drug-Eluting Stent Trial 3/7/2005
More...
|
Boston Scientific Corporation (BSX) Release: Results Of REALITY Trial Reaffirm Safety And Efficacy Of TAXUS(R) Express2(TM) Paclitaxel-Eluting Stent System 3/7/2005
More...
|
Boston Scientific Corporation (BSX) To Announce Results From Its TAXUS V Drug-Eluting Stent Clinical Trial, Studying Most Challenging Lesions And Highest-Risk Patients 3/3/2005
More...
|
GenVec Inc. (GNVC) Launches Phase IIB Trial In Patients With Severe Coronary Artery Disease 3/2/2005
More...
|
Atrium Medical Corporation Announces CE Approval For The HyperLite(TM) LX Rapid Exchange PTCA Catheter 3/2/2005
More...
|
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) Release: INTEGRILIN(R) (Eptifibatide) Injection When Added To Clopidogrel Provided Superior Platelet Inhibition And Reduced Heart Muscle Death, Based On The Release Of Cardiac Necrosis Biomarkers 3/1/2005
More...
|
Guilford Pharmaceuticals Inc. (GLFD) To Announce 2004 Year-End Financial Results On Tuesday, March 1, 2005 3/1/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Partner Announces Start Of Enrollment In World's Largest Drug-Eluting Stent Registry 2/23/2005
More...
|
Boston Scientific Corporation (BSX) Announces Start Of Enrollment In World's Largest Drug-Eluting Stent Registry 2/23/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Partner Announces Completion Of Enrollment In Pivotal Clinical Trial For Next-Generation Paclitaxel-Eluting Coronary Stent System 2/22/2005
More...
|
Boston Scientific Corporation (BSX) Announces Completion Of Enrollment In Pivotal Clinical Trial For Next-Generation Paclitaxel-Eluting Coronary Stent System 2/22/2005
More...
|
Conor Medsystems, Inc. Files Lawsuit To Revoke Angiotech Pharmaceuticals (ANPI) Patent 2/18/2005
More...
|
DISA Vascular's Small-Vessel Heart Stent Receives European Approval 2/17/2005
More...
|
Conor Medsystems, Inc. Announces Positive Six-Month Follow-Up Data From EuroSTAR Pivotal Study 2/17/2005
More...
|
CardioSoft Developing New Ischemia Detection Algorithms For Next-Generation Electrocardiogram 2/15/2005
More...
|
Fox Hollow Technologies, Inc. Release: One-Year Clinical Data On SilverHawk Plaque Excision System Presented At Arizona Heart International Congress 2/15/2005
More...
|
Distribution Of Cardiac Science (DFIB) Powerheart(R) AEDs Begins To U.S. Hospitals 2/10/2005
More...
|
Ventracor Limited (VCR.AX) Release: FDA Approves Feasibility Study For Australian Heart Assist Device In USA 2/9/2005
More...
|
GlaxoSmithKline (GSK) Release: The Risk Of Both Stroke And Coronary Heart Disease (CHD) Nearly Doubles With Elevated Lp-PLA2 Activity 2/8/2005
More...
|
Kensey Nash Corporation (KNSY) Updates TriActiv(R) System Regulatory And Sales Status 2/7/2005
More...
|
Cardiovascular Systems, Inc. Announces Approval For European Clinical Trial 2/3/2005
More...
|
Cardiovascular Systems, Inc. Announces First Marketing Clearance Of Its Orbital Atherectomy System 2/3/2005
More...
|
TyRx Pharma Inc. Announces Equity Investment By Boston Scientific Corporation (BSX) 2/1/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Announces Joint Law Suit Against Conor Medsystems, Inc. 2/1/2005
More...
|
Physician Feedback Is Extremely Positive As Boston Scientific Corporation (BSX) Completes Initial Launch Of TAXUS(R) Liberte(TM) Paclitaxel-Eluting Stent System 1/31/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Partner Says Physician Feedback Is Extremely Positive As It Completes Initial Launch Of TAXUS(R) Liberte(TM) Paclitaxel-Eluting Stent System 1/31/2005
More...
|
Southwestern Medical Advancing Designs For New Carotid Endarterectomy Shunt 1/31/2005
More...
|
FlowCardia, Inc. Receives European Regulatory Approval And Successfully Completes U.S. Feasibility Clinical Trial 1/28/2005
More...
|
Edwards Lifesciences (EW) To Start Percutaneous Heart Valve Clinical Trial In U.S. 1/28/2005
More...
|
Ventracor Limited (VCR.AX) Trial Results "Very Encouraging" 1/28/2005
More...
|
University of California, San Diego (UCSD) Cardiovascular Center To Host 8th Annual Heart Of San Diego Gala 1/28/2005
More...
|
Ariad Pharmaceuticals, Inc. (ARIA) Announces Collaboration With Medinol Ltd., Stent Technology Leader, To Develop AP23573 Drug-Delivery Stents 1/27/2005
More...
|
Edwards Lifesciences (EW) Realigns Its Japan Business 1/27/2005
More...
|
Terumo Corporation Introduces Minimally Invasive Endoscopic Saphenous Vein Harvesting System To The North American Market 1/27/2005
More...
|
Neich Medical Acquires Orbus Medical Technologies Inc. 1/26/2005
More...
|
Resverlogix Corporation (RVX.TO) Announces International Research Collaboration Program With Cedars-Sinai Medical Center And Atherosclerosis Researcher Dr. Prediman K. Shah 1/26/2005
More...
|
European Patent Office Maintains Validity Of Angiotech Pharmaceuticals's (ANPI) Paclitaxel-Eluting Stent Patent 1/24/2005
More...
|
Novadaq Technologies, Inc. Receives FDA Clearance For SPY Intra-Operative Imaging System For Cardiac Surgery 1/24/2005
More...
|
MedicalCV Inc. (MDCVU) Announces Completion Of First U.S. Clinical Case Using AtriLaze(TM) Surgical Ablation System In Open-Heart Surgery 1/24/2005
More...
|
Sorin Completes Enrollment Of Jupiter II Clinical Trial On Janus Carbostent 1/21/2005
More...
|
CryoLife, Inc. (CRY) Human Heart Valve Clinical Experience Report Demonstrates Positive Long-Term Outcomes 1/20/2005
More...
|
Cholestech (CTEC) Release: Simple Non-Invasive Fingertip Test Detects Coronary Disease Early 1/20/2005
More...
|
Boston Scientific Corporation (BSX) Announces Implantation Of Millionth TAXUS(R) Express2(TM) Coronary Stent System 1/19/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Partner Announces Implantation Of Millionth TAXUS(R) Express2(TM) Coronary Stent System 1/19/2005
More...
|
3F Therapeutics, Inc. Announces The First Clinical Implantation Of The 3F Enable Aortic Heart Valve, A Patented, Sutureless Implantation, Replacement Heart Valve Intended To Save Valuable Surgery Time 1/18/2005
More...
|
Abbott Laboratories (ABT) Announces Groundbreaking New Trial In Stroke Prevention 1/18/2005
More...
|
Boston Scientific Corporation (BSX) Is First To Market With Next-Generation Drug-Eluting Stent System 1/17/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Partner Is First To Market With Next-Generation Drug-Eluting Stent System 1/17/2005
More...
|
Terumo Corporation Launches PTCA Catheter With World's Smallest Diameter Catheter 1/13/2005
More...
|
IMI International Medical Innovations (IMI) Release: New Skin Sterol Data Published In Journal Of Clinical Chemistry 1/12/2005
More...
|
Study Supports Lp-PLA2 As Measured By diaDexus Plac(TM) Test As An Independent Risk Predictor Of Coronary Events And Strokes 1/11/2005
More...
|
First Fenestrated Endograft In Cook Inc.'s Study Of Advanced Treatment For Aortic Aneurysms Is Implanted In U.S. 1/7/2005
More...
|
NitroMed, Inc. (NTMD) Submits BiDil New Drug Application Amendment; Company Prepares For Commercialization Of First Heart Failure Treatment For African Americans 12/23/2004
More...
|
Nuvelo, Inc. (NUVO) Announces Phase 2 Alfimeprase Trial Results In Patients With Central Venous Catheter Occlusion To Be Presented At The American Society of Hematology (ASH) 46th Annual Meeting And Exposition 12/2/2004
More...
|
Boston Scientific Corporation (BSX) Exercises Right To Obtain Exclusive Paclitaxel License From Angiotech Pharmaceuticals (ANPI) 11/23/2004
More...
|
Boston Scientific Corporation (BSX) Release: French Government Expands Reimbursement For TAXUS(TM) Express 2(TM) Paclitaxel-Eluting Stent System 11/22/2004
More...
|
Angiotech Pharmaceuticals (ANPI) Release: French Government Expands Reimbursement For TAXUS(TM) Express(2)(TM) Paclitaxel-Eluting Stent System 11/22/2004
More...
|
STD Manufacturing Announces Sale Of AngioLink Corporation 11/19/2004
More...
|
MedicalCV Inc. (MDCVU) Announces Exit Of The Mechanical Heart Valve Business 11/19/2004
More...
|
Pfizer Inc.'s (PFE) Norvasc Demonstrates Significant Reductions In Major Cardiovascular Events In Patients With Coronary Artery Disease 11/10/2004
More...
|
Guilford Pharmaceuticals (GLFD) Announces Plans To Initiate Two Major Clinical Trials Evaluating AGGRASTATInjection In Percutaneous Coronary Intervention 8/12/2004
More...
|
Guilford Pharmaceuticals (GLFD) Release: New Clinical Trials Evaluate High-Dose AGGRASTAT In High-Risk Patients 7/29/2004
More...
|
EPIX Medical, Inc. (EPIX) Initiates MS-325 Clinical Trial For Cardiac Imaging; Blood Pool Contrast To Exploit Advanced MRI Technologies 7/12/2004
More...
|
Levosimendan Improves Function Of Stunned Myocardium After Angioplasty 6/25/2004
More...
|
CardioTech International, Inc. (CTE) Reports Update On Coronary Artery Bypass Graft Clinical Trials: Three Adult Patients Have Now Reached Critical Six Months Milestone 3/31/2004
More...
|
Terumo Corporation To Market New PTCA Guidewire 12/24/2003
More...
|
Biopure Corporation (BPUR) Initiates European Phase II Clinical Trial Of Hemopure In Coronary Angioplasty Patients 12/22/2003
More...
|
Acusphere Inc. Commences Pivotal Phase Of AI-700 Phase 3 Clinical Program 12/18/2003
More...
|
The Medicines Company's (MDCO) REPLACE-2 Trial One-Year Mortality Data Presented At American Heart Association's 2003 Scientific Sessions 11/11/2003
More...
|
Alexion Pharmaceuticals (ALXN) Announces Results Of Phase III PRIMO-CABG Trial Presented At The American Heart Association's Scientific Sessions 2003; Primary Endpoint Not Met; Alexion Hopeful 11/10/2003
More...
|
Merck & Co. (MRK) And Schering-Plough Corporation (SGP): Heart Disease Marker Detailed In Trial Results 11/10/2003
More...
|